Pediatric Soft Tissue Sarcomas

David M. Loeb, Katherine Thornton, Ori Shokek

Research output: Contribution to journalReview article

49 Citations (Scopus)

Abstract

Soft tissue sarcomas in children are rare. Approximately 850 to 900 children and adolescents are diagnosed each year with rhabdomyosarcoma (RMS) or a non-RMS soft tissue sarcoma (NRSTS). RMS is more common in children 14 years old and younger and NRSTS in adolescents and young adults. Infants get NRSTS, but their tumors constitute a distinctive set of histologies. Surgery is a major therapeutic modality and radiation plays a role. RMS is treated with adjuvant chemotherapy, whereas chemotherapy is reserved for the NRSTS that are high grade or unresectable. This review discusses the etiology, biology, and treatment of pediatric soft tissue sarcomas.

Original languageEnglish (US)
Pages (from-to)615-627
Number of pages13
JournalSurgical Clinics of North America
Volume88
Issue number3
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Sarcoma
Pediatrics
Rhabdomyosarcoma
Adjuvant Chemotherapy
Young Adult
Histology
Radiation
Drug Therapy
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Pediatric Soft Tissue Sarcomas. / Loeb, David M.; Thornton, Katherine; Shokek, Ori.

In: Surgical Clinics of North America, Vol. 88, No. 3, 01.06.2008, p. 615-627.

Research output: Contribution to journalReview article

Loeb, David M. ; Thornton, Katherine ; Shokek, Ori. / Pediatric Soft Tissue Sarcomas. In: Surgical Clinics of North America. 2008 ; Vol. 88, No. 3. pp. 615-627.
@article{b059daf7e9de42b7804ae5b70a33b6e7,
title = "Pediatric Soft Tissue Sarcomas",
abstract = "Soft tissue sarcomas in children are rare. Approximately 850 to 900 children and adolescents are diagnosed each year with rhabdomyosarcoma (RMS) or a non-RMS soft tissue sarcoma (NRSTS). RMS is more common in children 14 years old and younger and NRSTS in adolescents and young adults. Infants get NRSTS, but their tumors constitute a distinctive set of histologies. Surgery is a major therapeutic modality and radiation plays a role. RMS is treated with adjuvant chemotherapy, whereas chemotherapy is reserved for the NRSTS that are high grade or unresectable. This review discusses the etiology, biology, and treatment of pediatric soft tissue sarcomas.",
author = "Loeb, {David M.} and Katherine Thornton and Ori Shokek",
year = "2008",
month = "6",
day = "1",
doi = "10.1016/j.suc.2008.03.008",
language = "English (US)",
volume = "88",
pages = "615--627",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Pediatric Soft Tissue Sarcomas

AU - Loeb, David M.

AU - Thornton, Katherine

AU - Shokek, Ori

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Soft tissue sarcomas in children are rare. Approximately 850 to 900 children and adolescents are diagnosed each year with rhabdomyosarcoma (RMS) or a non-RMS soft tissue sarcoma (NRSTS). RMS is more common in children 14 years old and younger and NRSTS in adolescents and young adults. Infants get NRSTS, but their tumors constitute a distinctive set of histologies. Surgery is a major therapeutic modality and radiation plays a role. RMS is treated with adjuvant chemotherapy, whereas chemotherapy is reserved for the NRSTS that are high grade or unresectable. This review discusses the etiology, biology, and treatment of pediatric soft tissue sarcomas.

AB - Soft tissue sarcomas in children are rare. Approximately 850 to 900 children and adolescents are diagnosed each year with rhabdomyosarcoma (RMS) or a non-RMS soft tissue sarcoma (NRSTS). RMS is more common in children 14 years old and younger and NRSTS in adolescents and young adults. Infants get NRSTS, but their tumors constitute a distinctive set of histologies. Surgery is a major therapeutic modality and radiation plays a role. RMS is treated with adjuvant chemotherapy, whereas chemotherapy is reserved for the NRSTS that are high grade or unresectable. This review discusses the etiology, biology, and treatment of pediatric soft tissue sarcomas.

UR - http://www.scopus.com/inward/record.url?scp=44449105496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449105496&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2008.03.008

DO - 10.1016/j.suc.2008.03.008

M3 - Review article

C2 - 18514702

AN - SCOPUS:44449105496

VL - 88

SP - 615

EP - 627

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 3

ER -